VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 97 filers reported holding VERONA PHARMA PLC in Q1 2023. The put-call ratio across all filers is 1.24 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $32,752 | -83.9% | 2,265 | -82.1% | 0.00% | -100.0% |
| Q1 2024 | $203,892 | -10.2% | 12,672 | +10.9% | 0.00% | 0.0% |
| Q4 2023 | $227,169 | +15.0% | 11,427 | -5.7% | 0.00% | 0.0% |
| Q3 2023 | $197,507 | +5.4% | 12,117 | +36.8% | 0.00% | 0.0% |
| Q2 2023 | $187,300 | -81.8% | 8,860 | -77.5% | 0.00% | -50.0% |
| Q4 2022 | $1,028,790 | +1841.1% | 39,372 | +654.7% | 0.00% | – |
| Q3 2022 | $53,000 | – | 5,217 | +6503.8% | 0.00% | – |
| Q2 2022 | $0 | – | 79 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 79 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,115,352 | $16,127,990 | 6.98% |
| Caligan Partners LP | 1,843,756 | $26,660,712 | 6.23% |
| NEA Management Company, LLC | 5,584,753 | $80,755,528 | 6.08% |
| Alerce Investment Management, L.P. | 213,000 | $3,079,980 | 6.04% |
| Vivo Capital, LLC | 3,549,758 | $51,329,501 | 4.74% |
| Octagon Capital Advisors LP | 1,895,200 | $27,404,592 | 4.31% |
| Carlyle Group Inc. | 2,457,500 | $35,510,875 | 3.37% |
| Rosalind Advisors, Inc. | 250,000 | $3,615,000 | 2.78% |
| Frazier Life Sciences Management, L.P. | 3,314,349 | $47,925,487 | 2.24% |
| Knoll Capital Management, LLC | 200,000 | $2,892,000 | 1.95% |